Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer.
Goodlad, R A
Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. [electronic resource] - Carcinogenesis Oct 2006 - 2133-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0143-3334
10.1093/carcin/bgl113 doi
Adenoma--prevention & control
Animals
Female
Genes, APC--physiology
Intestinal Neoplasms--prevention & control
Intestinal Polyps--drug therapy
Male
Mice
Mice, Inbred C57BL
Quinazolines--therapeutic use
RNA, Messenger--analysis
Signal Transduction--drug effects
Splenomegaly--prevention & control
Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors
Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. [electronic resource] - Carcinogenesis Oct 2006 - 2133-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0143-3334
10.1093/carcin/bgl113 doi
Adenoma--prevention & control
Animals
Female
Genes, APC--physiology
Intestinal Neoplasms--prevention & control
Intestinal Polyps--drug therapy
Male
Mice
Mice, Inbred C57BL
Quinazolines--therapeutic use
RNA, Messenger--analysis
Signal Transduction--drug effects
Splenomegaly--prevention & control
Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors